Japan Medical Dynamic Marketing, INC.

TSE:7600 Stock Report

Market Cap: JP¥16.1b

Japan Medical Dynamic Marketing Future Growth

Future criteria checks 3/6

Japan Medical Dynamic Marketing is forecast to grow earnings and revenue by 14.9% and 9.1% per annum respectively. EPS is expected to grow by 14.9% per annum. Return on equity is forecast to be 6.4% in 3 years.

Key information

14.9%

Earnings growth rate

14.9%

EPS growth rate

Healthcare earnings growth8.4%
Revenue growth rate9.1%
Future return on equity6.4%
Analyst coverage

Low

Last updated19 Nov 2024

Recent future growth updates

Recent updates

Japan Medical Dynamic Marketing (TSE:7600) Is Paying Out A Larger Dividend Than Last Year

Jan 02
Japan Medical Dynamic Marketing (TSE:7600) Is Paying Out A Larger Dividend Than Last Year

Japan Medical Dynamic Marketing's (TSE:7600) Upcoming Dividend Will Be Larger Than Last Year's

Dec 01
Japan Medical Dynamic Marketing's (TSE:7600) Upcoming Dividend Will Be Larger Than Last Year's

Japan Medical Dynamic Marketing's (TSE:7600) Shareholders Will Receive A Bigger Dividend Than Last Year

Nov 01
Japan Medical Dynamic Marketing's (TSE:7600) Shareholders Will Receive A Bigger Dividend Than Last Year

We Think You Can Look Beyond Japan Medical Dynamic Marketing's (TSE:7600) Lackluster Earnings

May 07
We Think You Can Look Beyond Japan Medical Dynamic Marketing's (TSE:7600) Lackluster Earnings

Japan Medical Dynamic Marketing (TSE:7600) Will Pay A Larger Dividend Than Last Year At ¥14.00

Mar 12
Japan Medical Dynamic Marketing (TSE:7600) Will Pay A Larger Dividend Than Last Year At ¥14.00

Japan Medical Dynamic Marketing's (TSE:7600) Upcoming Dividend Will Be Larger Than Last Year's

Feb 27
Japan Medical Dynamic Marketing's (TSE:7600) Upcoming Dividend Will Be Larger Than Last Year's

Earnings and Revenue Growth Forecasts

TSE:7600 - Analysts future estimates and past financials data (JPY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/202730,0001,950N/A3,1241
3/31/202627,2001,500N/A2,6951
3/31/202524,8001,300N/A1,8991
9/30/202424,0421,408-3111,470N/A
6/30/202423,8281,368N/AN/AN/A
3/31/202423,1771,2713022,104N/A
12/31/202322,6761,017N/AN/AN/A
9/30/202322,2701,0611781,830N/A
6/30/202321,6821,264N/AN/AN/A
3/31/202321,3071,4238712,186N/A
12/31/202220,8391,639N/AN/AN/A
9/30/202220,3241,8531,4412,985N/A
6/30/202219,6832,108N/AN/AN/A
3/31/202219,1932,1351,5263,111N/A
12/31/202118,4082,281N/AN/AN/A
9/30/202117,8432,1411,7573,006N/A
6/30/202117,8661,896N/AN/AN/A
3/31/202116,7381,6641,2282,599N/A
12/31/202016,8841,725N/AN/AN/A
9/30/202017,0541,7689642,476N/A
6/30/202017,1281,847N/AN/AN/A
3/31/202018,0832,1649462,731N/A
12/31/201918,1942,308N/AN/AN/A
9/30/201917,9592,3124252,361N/A
6/30/201917,3292,116N/AN/AN/A
3/31/201916,7281,9842742,367N/A
12/31/201816,2031,584N/AN/AN/A
9/30/201815,7441,5327202,230N/A
6/30/201815,2011,461N/AN/AN/A
3/31/201814,8071,425N/A2,562N/A
12/31/201714,3731,258N/AN/AN/A
9/30/201713,8471,137N/A2,313N/A
6/30/201713,7691,200N/AN/AN/A
3/31/201713,6291,130N/A2,038N/A
12/31/201613,453996N/AN/AN/A
9/30/201613,248947N/A1,981N/A
6/30/201613,207829N/AN/AN/A
3/31/201613,024800N/A1,566N/A
12/31/201512,849-251N/AN/AN/A
9/30/201512,708-273N/A2,004N/A
6/30/201512,269-321N/AN/AN/A
3/31/201511,855-391N/A1,967N/A
12/31/201411,272708N/AN/AN/A
9/30/201410,610521N/A387N/A
6/30/201410,042463N/AN/AN/A
3/31/20149,459286N/A-457N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 7600's forecast earnings growth (14.9% per year) is above the savings rate (0.3%).

Earnings vs Market: 7600's earnings (14.9% per year) are forecast to grow faster than the JP market (8.1% per year).

High Growth Earnings: 7600's earnings are forecast to grow, but not significantly.

Revenue vs Market: 7600's revenue (9.1% per year) is forecast to grow faster than the JP market (4.3% per year).

High Growth Revenue: 7600's revenue (9.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 7600's Return on Equity is forecast to be low in 3 years time (6.4%).


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/22 18:09
End of Day Share Price 2025/01/22 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Japan Medical Dynamic Marketing, INC. is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hidemaru YamaguchiCitigroup Inc
Masatoshi NagataIchiyoshi Research Institute Inc.
Motoya KohtaniNomura Securities Co. Ltd.